b'VISIONARY RESEARCHERSPCRF supported these imaginative and far-sighted scientists whose findings set the stage for future advances in care:Mitchell Cairo, MDNew York Medical College, Marie Fareri Childrens HospitalCancer genetics, tumor immunology and targeted treatments forchildhood and adolescent hematological malignancies and solid tumorsBrian Crompton, MDDana-Farber Cancer InstituteImproved diagnostic and treatment tools for Ewing SarcomaJosephine HaDuong, MDChildrens Hospital of Orange County and University of California Medical Center IrvineEstablishing a pediatric medulloblastoma testing pipelineMichael Hogarty, MDChildrens Hospital of PhiladelphiaDeveloping user-friendly tests to determine the appropriateprotein-based treatment response for childhood neuroblastomasEugenie Kleinerman, MDMD Anderson Cancer CenterA novel dendritic cell vaccine and anti-PD1 for osteosarcoma therapyTheodore Moore, MDMattel Childrens Hospital, UCLAPhase I/II therapeutic research trials and development of newtreatment modality for incurable brain tumors Ashley Plant-Fox, MDAnn & Robert H. Lurie Childrens Hospital of ChicagoCombination immunotherapy for Diffuse Intrinsic Pontine Glioma (DIPG)Kathleen Sakamoto, MD, PhDLucille Packard Childrens Hospital StanfordTargeting mitochondrial pathways in Pediatric AMLNader Sanai, MD, FAANS, FACS Ivy Brain Tumor Center at Barrow Neurological InstituteDrug-targeting in ependymoma patients with YAP1 fusionSurojit Sarkar, PhDSeattle Childrens Hospital Using bioengineered CAR T cell therapy to switch off solid tumorsElliot Stieglitz, MDUniversity of California, San Francisco Benioff Childrens HospitalInnovative tests to determine treatment responsiveness for Juvenilemyelomonocytic leukemia (JMML)Rajkumar Venkatramani, MDTexas Childrens HospitalMolecular characterization of undifferentiated sarcomasLeo Wang, PhD City of Hope National Medical CenterFine-tuning chimeric antigen receptor T Cells for pediatric brain tumors9'